Baxter International (BAX) Stock Price, News & Analysis

Company Overview

Baxter International Inc. is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters. The company’s medication delivery products include infusion pumps, administration sets and patient-controlled analgesia systems, while its parenteral nutrition and pharmacy automation solutions help healthcare providers manage and deliver intravenous nutrition and medication safely and efficiently.

Baxter’s surgical and bioScience portfolio features advanced surgical sealants, hemostats and adhesion barriers, as well as devices for cell therapy, membrane plasmapheresis and laboratory separations. These products support a range of critical care applications, from intraoperative bleeding control to therapeutic apheresis and regenerative medicine research.

Founded in 1931 and headquartered in Deerfield, Illinois, Baxter operates in more than 100 countries and employs over 50,000 people. The company is led by Chairman and Chief Executive Officer José E. Almeida, under whose leadership Baxter has continued to invest in research and development, strategic partnerships and targeted acquisitions aimed at addressing evolving patient and healthcare provider needs around the world.

Key Stats

• Today's Range: $22.59 to $23.71
• 50-Day Range: $17.30 to $23.36
• 52-Week Range: $15.73 to $29.35
• Volume: 6.55 million shs
• Average Volume: 5.44 million shs
• Market Capitalization: $11.67 billion
• P/E Ratio: N/A
• Dividend Yield: 0.18%
• Price Target: $19.91
• Consensus Rating: Reduce

Baxter International Stock Analysis - MarketRank™

Baxter International scored higher than 29% of companies evaluated by MarketBeat, and ranked 741st out of 848 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.9 / 5
• Analyst Rating: Reduce

Consensus Rating

Baxter International has received a consensus rating of Reduce. The company's average rating score is 1.85, and is based on no strong buy ratings, 2 buy ratings, 7 hold ratings, and 4 sell ratings.

Downside Risk

Baxter International has a consensus price target of $19.91, representing about 11.9% downside from its current price of $22.61.

Amount of Analyst Coverage

Baxter International has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: 2.62%

Earnings Growth

Earnings for Baxter International are expected to grow by 2.62% in the coming year, from $1.91 to $1.96 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Baxter International is -10.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Baxter International is -10.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Baxter International has a PEG Ratio of 3.77. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Baxter International has a P/B Ratio of 1.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

7.48% of the float of Baxter International has been sold short.

Short Interest Ratio / Days to Cover

Baxter International has a short interest ratio ("days to cover") of 5.47.

Change versus previous month

Short interest in Baxter International has recently decreased by 7.38%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Baxter International has a dividend yield of 0.17%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Baxter International does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Baxter International will have a dividend payout ratio of 2.04% next year. This indicates that Baxter International will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.20

News Sentiment

Baxter International has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 19 news articles for Baxter International this week, compared to 12 articles on an average week.

Search Interest

Only 7 people have searched for BAX on MarketBeat in the last 30 days. This is a decrease of -46% compared to the previous 30 days.

MarketBeat Follows

Only 5 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Baxter International insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.17% of the stock of Baxter International is held by insiders.

Percentage Held by Institutions

90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 4/30/2026
• Record date for 7/1 Dividend: 5/29/2026
• Ex-Dividend for 7/1 Dividend: 5/29/2026
• Dividend Payable: 7/01/2026
• Today: 7/18/2026
• Next Earnings (Estimated): 7/30/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:BAX
• CIK: 10456
• Web: www.baxter.com
• Phone: (224) 948-2000
• Fax: 224-948-1813
• Employees: 37,500
• Year Founded: 1931

Price Target and Rating

• Average Price Target for Baxter International: $19.91
• High Price Target: $27.00
• Low Price Target: $15.00
• Potential Upside/Downside: -11.9%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.85
• Research Coverage: 13 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.13)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 11.84
• P/E Growth: 3.77
• Net Income: -$957 million
• Net Margins: -9.70%
• Pretax Margin: -4.49%
• Return on Equity: 16.15%
• Return on Assets: 5.24%

Debt

• Debt-to-Equity Ratio: 1.43
• Current Ratio: 1.85
• Quick Ratio: 1.23

Sales & Book Value

• Annual Sales: $11.24 billion
• Price / Sales: 1.04
• Cash Flow: $5.50 per share
• Price / Cash Flow: 4.11
• Book Value: $11.87 per share
• Price / Book: 1.90

Miscellaneous

• Outstanding Shares: 516,470,000
• Free Float: 515,591,000
• Market Cap: $11.67 billion
• Optionable: Optionable
• Beta: 0.62